| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 732851 | 1-[3-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-2-chloro-5-trifluoromethylbenzene | 0.0241085022307781 | 0.21382454 |
| NSC 734977 | Ethyl N-[4-(10-methyl-3-phenyl-4H-indolo[3,2-e][1,2,3]triazolo [1,5-a]pyrimidin-4-yl)butanoyl]glycinate | 0.0241085022307781 | -0.19990937 |
| NSC 735318 | Null | 0.0241085022307781 | 0.2567214 |
| NSC 736179 | 1,2-Dithiolan-3-yl-N-(3'-methoxyestra-1',3',5'(10')-triene-1 7'b-yl)pentanamide | 0.0241085022307781 | 0.37308707 |
| NSC 740276 | 5,6-Dihydro-6-[3-(hydroxyethyl)amino-1-propyl]-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloide | 0.0241085022307781 | 0.20732558 |
| NSC 740385 | 7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide | 0.0241085022307781 | 0.28505109 |
| NSC 126228 | Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) | 0.0247979034812109 | 0.10873345 |
| NSC 163424 | 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- | 0.0247979034812109 | 0.30477207 |
| NSC 300289 | Pinafide | 0.0247979034812109 | 0.010495134 |
| NSC 303861 | L-Cysteine analog | 0.0247979034812109 | 0.30240238 |